Ballentine Partners LLC Increases Position in Keurig Dr Pepper, Inc $KDP

Ballentine Partners LLC boosted its position in Keurig Dr Pepper, Inc (NASDAQ:KDP) by 31.0% in the 2nd quarter, according to its most recent filing with the SEC. The firm owned 26,006 shares of the company’s stock after acquiring an additional 6,152 shares during the period. Ballentine Partners LLC’s holdings in Keurig Dr Pepper were worth $860,000 at the end of the most recent reporting period.

Other institutional investors also recently bought and sold shares of the company. Commerce Bank increased its stake in Keurig Dr Pepper by 1.6% in the first quarter. Commerce Bank now owns 21,513 shares of the company’s stock valued at $736,000 after purchasing an additional 340 shares during the last quarter. First American Bank increased its stake in shares of Keurig Dr Pepper by 0.6% during the 1st quarter. First American Bank now owns 59,564 shares of the company’s stock valued at $2,038,000 after acquiring an additional 344 shares during the last quarter. Allworth Financial LP lifted its holdings in shares of Keurig Dr Pepper by 3.8% during the 1st quarter. Allworth Financial LP now owns 10,242 shares of the company’s stock worth $353,000 after acquiring an additional 371 shares during the period. Citadel Investment Advisory Inc. boosted its position in shares of Keurig Dr Pepper by 6.6% in the first quarter. Citadel Investment Advisory Inc. now owns 6,445 shares of the company’s stock worth $221,000 after acquiring an additional 400 shares during the last quarter. Finally, Hartford Funds Management Co LLC grew its holdings in Keurig Dr Pepper by 1.2% in the first quarter. Hartford Funds Management Co LLC now owns 34,497 shares of the company’s stock valued at $1,180,000 after purchasing an additional 413 shares during the period. 93.99% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on KDP. BNP Paribas downgraded shares of Keurig Dr Pepper from a “neutral” rating to an “underperform” rating in a research note on Monday. Barclays lowered Keurig Dr Pepper from an “overweight” rating to an “equal weight” rating and cut their target price for the stock from $39.00 to $26.00 in a research report on Wednesday. HSBC reissued a “hold” rating and set a $30.00 price target (down previously from $42.00) on shares of Keurig Dr Pepper in a research report on Tuesday, August 26th. BNP Paribas Exane downgraded Keurig Dr Pepper from a “neutral” rating to an “underperform” rating in a report on Monday. Finally, Wells Fargo & Company reduced their price objective on Keurig Dr Pepper from $40.00 to $33.00 and set an “overweight” rating on the stock in a research note on Thursday. Ten investment analysts have rated the stock with a Buy rating, four have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat.com, Keurig Dr Pepper presently has a consensus rating of “Moderate Buy” and an average price target of $36.23.

Insider Buying and Selling at Keurig Dr Pepper

In related news, insider Mary Beth Denooyer sold 12,000 shares of the firm’s stock in a transaction on Thursday, July 17th. The shares were sold at an average price of $33.66, for a total transaction of $403,920.00. Following the completion of the sale, the insider directly owned 82,511 shares of the company’s stock, valued at approximately $2,777,320.26. This trade represents a 12.70% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Robert James Gamgort sold 208,000 shares of Keurig Dr Pepper stock in a transaction on Friday, August 1st. The stock was sold at an average price of $32.90, for a total transaction of $6,843,200.00. Following the sale, the director directly owned 2,292,169 shares in the company, valued at $75,412,360.10. This trade represents a 8.32% decrease in their position. The disclosure for this sale can be found here. Insiders sold 447,601 shares of company stock valued at $14,825,192 over the last 90 days. Insiders own 0.40% of the company’s stock.

Keurig Dr Pepper Trading Down 1.9%

Shares of KDP opened at $25.75 on Friday. Keurig Dr Pepper, Inc has a 12 month low of $25.67 and a 12 month high of $37.82. The stock’s 50-day moving average is $31.11 and its two-hundred day moving average is $32.84. The company has a debt-to-equity ratio of 0.56, a current ratio of 0.64 and a quick ratio of 0.40. The stock has a market cap of $34.98 billion, a PE ratio of 22.99, a P/E/G ratio of 1.44 and a beta of 0.47.

Keurig Dr Pepper (NASDAQ:KDP) last announced its earnings results on Thursday, July 24th. The company reported $0.49 EPS for the quarter, meeting the consensus estimate of $0.49. The business had revenue of $4.16 billion for the quarter, compared to the consensus estimate of $4.14 billion. Keurig Dr Pepper had a return on equity of 11.05% and a net margin of 9.75%.The company’s revenue was up 6.1% on a year-over-year basis. During the same period last year, the business posted $0.45 EPS. Equities analysts forecast that Keurig Dr Pepper, Inc will post 1.92 earnings per share for the current fiscal year.

Keurig Dr Pepper Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 10th. Stockholders of record on Friday, September 26th will be given a dividend of $0.23 per share. This represents a $0.92 dividend on an annualized basis and a dividend yield of 3.6%. The ex-dividend date of this dividend is Friday, September 26th. Keurig Dr Pepper’s payout ratio is presently 82.14%.

About Keurig Dr Pepper

Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.